Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: S&P Capital IQ Quantitative Report
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sangamo Biosciences Inc Reaffirms FY 2013 Revenue Guidance-Conference Call

Tuesday, 27 Aug 2013 07:30am EDT 

Sangamo Biosciences Inc announced that for fiscal 2013, it expects revenues to be in the range of $20 million to $24 million. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $24 million for fiscal 2013. 

Company Quote

0.04 +0.40%
11:38am EDT